How big is the aneurysmal subarachnoid hemorrhage market?

Aneurysmal subarachnoid hemorrhage is a condition wherein a brain aneurysm ruptures resulting in bleeding into the subarachnoid space.Market Analysis and Insights Global Aneurysmal Subarachnoid Hemorrhage MarketThe global Aneurysmal Subarachnoid Hemorrhage market size is projected to reach US 175.3 million by 2027 from US 151.9 million in 2020 at a CAGR of 2.0 during 20212027.With industrystandard accuracy in analysis and high data integrity the report makes a brilliant attempt to unveil key opportunities available in the global Aneurysmal Subarachnoid Hemorrhage market to help players in achieving a strong market position.

Global Aneurysmal Subarachnoid Hemorrhage Market Insights Forecast to 2028

BUY CHAPTERS

Global Aneurysmal Subarachnoid Hemorrhage Market Insights, Forecast to 2029

Code: QYRE-Auto-8O6254

Report

May 2023

Pages:112

QYResearch

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Edge Therapeutics

Actelion Pharmaceuticals

Arbor Pharmaceuticals

Mayfield Brain & Spine

Aneurysmal Subarachnoid Hemorrhage Market Size

The global Aneurysmal Subarachnoid Hemorrhage market is projected to grow from US$ 155.2 million in 2023 to US$ 175.3 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.0% during the forecast period.

Aneurysmal Subarachnoid Hemorrhage Market

Market Analysis and Insights: Global Aneurysmal Subarachnoid Hemorrhage Market

Aneurysmal subarachnoid hemorrhage is a condition wherein a brain aneurysm ruptures, resulting in bleeding into the subarachnoid space.

Report Includes

This report presents an overview of global market for Aneurysmal Subarachnoid Hemorrhage market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Aneurysmal Subarachnoid Hemorrhage, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Aneurysmal Subarachnoid Hemorrhage, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Aneurysmal Subarachnoid Hemorrhage revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Aneurysmal Subarachnoid Hemorrhage market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Aneurysmal Subarachnoid Hemorrhage revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Edge Therapeutics, Actelion Pharmaceuticals, Arbor Pharmaceuticals, Mayfield Brain & Spine, Europa Group, GE, Philips, Siemens and Trivitron, etc.

Scope of Aneurysmal Subarachnoid Hemorrhage Market Report

Report Metric	Details
Report Name	Aneurysmal Subarachnoid Hemorrhage Market
Accounted market size in 2023	US$ 155.2 million
Forecasted market size in 2029	US$ 175.3 million
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Computed Tomography (CT) Scan Magnetic Resonance Imaging (MRI) Lumbar Puncture Xanthochromia Cerebral Angiography Transcranial Doppler Ultrasound
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Edge Therapeutics, Actelion Pharmaceuticals, Arbor Pharmaceuticals, Mayfield Brain & Spine, Europa Group, GE, Philips, Siemens, Trivitron, Toshiba
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Aneurysmal Subarachnoid Hemorrhage in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Aneurysmal Subarachnoid Hemorrhage companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aneurysmal Subarachnoid Hemorrhage revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Aneurysmal Subarachnoid Hemorrhage Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Computed Tomography (CT) Scan

1.2.3 Magnetic Resonance Imaging (MRI)

1.2.4 Lumbar Puncture

1.2.5 Xanthochromia

1.2.6 Cerebral Angiography

1.2.7 Transcranial Doppler Ultrasound

1.3 Market by Application

1.3.1 Global Aneurysmal Subarachnoid Hemorrhage Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Aneurysmal Subarachnoid Hemorrhage Market Perspective (2018-2029)

2.2 Global Aneurysmal Subarachnoid Hemorrhage Growth Trends by Region

2.2.1 Aneurysmal Subarachnoid Hemorrhage Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Aneurysmal Subarachnoid Hemorrhage Historic Market Size by Region (2018-2023)

2.2.3 Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Region (2024-2029)

2.3 Aneurysmal Subarachnoid Hemorrhage Market Dynamics

2.3.1 Aneurysmal Subarachnoid Hemorrhage Industry Trends

2.3.2 Aneurysmal Subarachnoid Hemorrhage Market Drivers

2.3.3 Aneurysmal Subarachnoid Hemorrhage Market Challenges

2.3.4 Aneurysmal Subarachnoid Hemorrhage Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Aneurysmal Subarachnoid Hemorrhage by Players

3.1.1 Global Aneurysmal Subarachnoid Hemorrhage Revenue by Players (2018-2023)

3.1.2 Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Players (2018-2023)

3.2 Global Aneurysmal Subarachnoid Hemorrhage Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Aneurysmal Subarachnoid Hemorrhage, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Aneurysmal Subarachnoid Hemorrhage Market Concentration Ratio

3.4.1 Global Aneurysmal Subarachnoid Hemorrhage Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Aneurysmal Subarachnoid Hemorrhage Revenue in 2022

3.5 Global Key Players of Aneurysmal Subarachnoid Hemorrhage Head office and Area Served

3.6 Global Key Players of Aneurysmal Subarachnoid Hemorrhage, Product and Application

3.7 Global Key Players of Aneurysmal Subarachnoid Hemorrhage, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Aneurysmal Subarachnoid Hemorrhage Breakdown Data by Type

4.1 Global Aneurysmal Subarachnoid Hemorrhage Historic Market Size by Type (2018-2023)

4.2 Global Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Type (2024-2029)

5 Aneurysmal Subarachnoid Hemorrhage Breakdown Data by Application

5.1 Global Aneurysmal Subarachnoid Hemorrhage Historic Market Size by Application (2018-2023)

5.2 Global Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Aneurysmal Subarachnoid Hemorrhage Market Size (2018-2029)

6.2 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Type

6.2.1 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2018-2023)

6.2.2 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2024-2029)

6.2.3 North America Aneurysmal Subarachnoid Hemorrhage Market Share by Type (2018-2029)

6.3 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Application

6.3.1 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2018-2023)

6.3.2 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2024-2029)

6.3.3 North America Aneurysmal Subarachnoid Hemorrhage Market Share by Application (2018-2029)

6.4 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Country

6.4.1 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2018-2023)

6.4.3 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Aneurysmal Subarachnoid Hemorrhage Market Size (2018-2029)

7.2 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Type

7.2.1 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2018-2023)

7.2.2 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2024-2029)

7.2.3 Europe Aneurysmal Subarachnoid Hemorrhage Market Share by Type (2018-2029)

7.3 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Application

7.3.1 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2018-2023)

7.3.2 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2024-2029)

7.3.3 Europe Aneurysmal Subarachnoid Hemorrhage Market Share by Application (2018-2029)

7.4 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Country

7.4.1 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2018-2023)

7.4.3 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Aneurysmal Subarachnoid Hemorrhage Market Size (2018-2029)

8.2 China Aneurysmal Subarachnoid Hemorrhage Market Size by Type

8.2.1 China Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2018-2023)

8.2.2 China Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2024-2029)

8.2.3 China Aneurysmal Subarachnoid Hemorrhage Market Share by Type (2018-2029)

8.3 China Aneurysmal Subarachnoid Hemorrhage Market Size by Application

8.3.1 China Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2018-2023)

8.3.2 China Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2024-2029)

8.3.3 China Aneurysmal Subarachnoid Hemorrhage Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Aneurysmal Subarachnoid Hemorrhage Market Size (2018-2029)

9.2 Asia Aneurysmal Subarachnoid Hemorrhage Market Size by Type

9.2.1 Asia Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2018-2023)

9.2.2 Asia Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2024-2029)

9.2.3 Asia Aneurysmal Subarachnoid Hemorrhage Market Share by Type (2018-2029)

9.3 Asia Aneurysmal Subarachnoid Hemorrhage Market Size by Application

9.3.1 Asia Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2018-2023)

9.3.2 Asia Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2024-2029)

9.3.3 Asia Aneurysmal Subarachnoid Hemorrhage Market Share by Application (2018-2029)

9.4 Asia Aneurysmal Subarachnoid Hemorrhage Market Size by Region

9.4.1 Asia Aneurysmal Subarachnoid Hemorrhage Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Aneurysmal Subarachnoid Hemorrhage Market Size by Region (2018-2023)

9.4.3 Asia Aneurysmal Subarachnoid Hemorrhage Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Type

10.2.1 Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Application

10.3.1 Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Country

10.4.1 Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Edge Therapeutics

11.1.1 Edge Therapeutics Company Details

11.1.2 Edge Therapeutics Business Overview

11.1.3 Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Introduction

11.1.4 Edge Therapeutics Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

11.1.5 Edge Therapeutics Recent Developments

11.2 Actelion Pharmaceuticals

11.2.1 Actelion Pharmaceuticals Company Details

11.2.2 Actelion Pharmaceuticals Business Overview

11.2.3 Actelion Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Introduction

11.2.4 Actelion Pharmaceuticals Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

11.2.5 Actelion Pharmaceuticals Recent Developments

11.3 Arbor Pharmaceuticals

11.3.1 Arbor Pharmaceuticals Company Details

11.3.2 Arbor Pharmaceuticals Business Overview

11.3.3 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Introduction

11.3.4 Arbor Pharmaceuticals Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

11.3.5 Arbor Pharmaceuticals Recent Developments

11.4 Mayfield Brain & Spine

11.4.1 Mayfield Brain & Spine Company Details

11.4.2 Mayfield Brain & Spine Business Overview

11.4.3 Mayfield Brain & Spine Aneurysmal Subarachnoid Hemorrhage Introduction

11.4.4 Mayfield Brain & Spine Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

11.4.5 Mayfield Brain & Spine Recent Developments

11.5 Europa Group

11.5.1 Europa Group Company Details

11.5.2 Europa Group Business Overview

11.5.3 Europa Group Aneurysmal Subarachnoid Hemorrhage Introduction

11.5.4 Europa Group Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

11.5.5 Europa Group Recent Developments

11.6 GE

11.6.1 GE Company Details

11.6.2 GE Business Overview

11.6.3 GE Aneurysmal Subarachnoid Hemorrhage Introduction

11.6.4 GE Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

11.6.5 GE Recent Developments

11.7 Philips

11.7.1 Philips Company Details

11.7.2 Philips Business Overview

11.7.3 Philips Aneurysmal Subarachnoid Hemorrhage Introduction

11.7.4 Philips Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

11.7.5 Philips Recent Developments

11.8 Siemens

11.8.1 Siemens Company Details

11.8.2 Siemens Business Overview

11.8.3 Siemens Aneurysmal Subarachnoid Hemorrhage Introduction

11.8.4 Siemens Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

11.8.5 Siemens Recent Developments

11.9 Trivitron

11.9.1 Trivitron Company Details

11.9.2 Trivitron Business Overview

11.9.3 Trivitron Aneurysmal Subarachnoid Hemorrhage Introduction

11.9.4 Trivitron Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

11.9.5 Trivitron Recent Developments

11.10 Toshiba

11.10.1 Toshiba Company Details

11.10.2 Toshiba Business Overview

11.10.3 Toshiba Aneurysmal Subarachnoid Hemorrhage Introduction

11.10.4 Toshiba Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

11.10.5 Toshiba Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Edge Therapeutics

Actelion Pharmaceuticals

Arbor Pharmaceuticals

Mayfield Brain & Spine

List of Tables

Table 1. Global Aneurysmal Subarachnoid Hemorrhage Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Computed Tomography (CT) Scan

Table 3. Key Players of Magnetic Resonance Imaging (MRI)

Table 4. Key Players of Lumbar Puncture

Table 5. Key Players of Xanthochromia

Table 6. Key Players of Cerebral Angiography

Table 7. Key Players of Transcranial Doppler Ultrasound

Table 8. Global Aneurysmal Subarachnoid Hemorrhage Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 9. Global Aneurysmal Subarachnoid Hemorrhage Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 10. Global Aneurysmal Subarachnoid Hemorrhage Market Size by Region (2018-2023) & (US$ Million)

Table 11. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Region (2018-2023)

Table 12. Global Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 13. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Region (2024-2029)

Table 14. Aneurysmal Subarachnoid Hemorrhage Market Trends

Table 15. Aneurysmal Subarachnoid Hemorrhage Market Drivers

Table 16. Aneurysmal Subarachnoid Hemorrhage Market Challenges

Table 17. Aneurysmal Subarachnoid Hemorrhage Market Restraints

Table 18. Global Aneurysmal Subarachnoid Hemorrhage Revenue by Players (2018-2023) & (US$ Million)

Table 19. Global Aneurysmal Subarachnoid Hemorrhage Revenue Share by Players (2018-2023)

Table 20. Global Top Aneurysmal Subarachnoid Hemorrhage by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aneurysmal Subarachnoid Hemorrhage as of 2022)

Table 21. Global Aneurysmal Subarachnoid Hemorrhage Industry Ranking 2021 VS 2022 VS 2023

Table 22. Global 5 Largest Players Market Share by Aneurysmal Subarachnoid Hemorrhage Revenue (CR5 and HHI) & (2018-2023)

Table 23. Global Key Players of Aneurysmal Subarachnoid Hemorrhage, Headquarters and Area Served

Table 24. Global Key Players of Aneurysmal Subarachnoid Hemorrhage, Product and Application

Table 25. Global Key Players of Aneurysmal Subarachnoid Hemorrhage, Product and Application

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2018-2023) & (US$ Million)

Table 28. Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Type (2018-2023)

Table 29. Global Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 30. Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Type (2024-2029)

Table 31. Global Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2018-2023) & (US$ Million)

Table 32. Global Aneurysmal Subarachnoid Hemorrhage Revenue Share by Application (2018-2023)

Table 33. Global Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 34. Global Aneurysmal Subarachnoid Hemorrhage Revenue Share by Application (2024-2029)

Table 35. North America Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2018-2023) & (US$ Million)

Table 36. North America Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2024-2029) & (US$ Million)

Table 37. North America Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2018-2023) & (US$ Million)

Table 38. North America Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2024-2029) & (US$ Million)

Table 39. North America Aneurysmal Subarachnoid Hemorrhage Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 40. North America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2018-2023) & (US$ Million)

Table 41. North America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2024-2029) & (US$ Million)

Table 42. Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2018-2023) & (US$ Million)

Table 43. Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2024-2029) & (US$ Million)

Table 44. Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2018-2023) & (US$ Million)

Table 45. Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2024-2029) & (US$ Million)

Table 46. Europe Aneurysmal Subarachnoid Hemorrhage Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 47. Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2018-2023) & (US$ Million)

Table 48. Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2024-2029) & (US$ Million)

Table 49. China Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2018-2023) & (US$ Million)

Table 50. China Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2024-2029) & (US$ Million)

Table 51. China Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2018-2023) & (US$ Million)

Table 52. China Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2024-2029) & (US$ Million)

Table 53. Asia Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2018-2023) & (US$ Million)

Table 54. Asia Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2024-2029) & (US$ Million)

Table 55. Asia Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2018-2023) & (US$ Million)

Table 56. Asia Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2024-2029) & (US$ Million)

Table 57. Asia Aneurysmal Subarachnoid Hemorrhage Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 58. Asia Aneurysmal Subarachnoid Hemorrhage Market Size by Region (2018-2023) & (US$ Million)

Table 59. Asia Aneurysmal Subarachnoid Hemorrhage Market Size by Region (2024-2029) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2018-2023) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2024-2029) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2018-2023) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2024-2029) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 65. Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2018-2023) & (US$ Million)

Table 66. Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2024-2029) & (US$ Million)

Table 67. Edge Therapeutics Company Details

Table 68. Edge Therapeutics Business Overview

Table 69. Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Product

Table 70. Edge Therapeutics Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023) & (US$ Million)

Table 71. Edge Therapeutics Recent Developments

Table 72. Actelion Pharmaceuticals Company Details

Table 73. Actelion Pharmaceuticals Business Overview

Table 74. Actelion Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Product

Table 75. Actelion Pharmaceuticals Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023) & (US$ Million)

Table 76. Actelion Pharmaceuticals Recent Developments

Table 77. Arbor Pharmaceuticals Company Details

Table 78. Arbor Pharmaceuticals Business Overview

Table 79. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Product

Table 80. Arbor Pharmaceuticals Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023) & (US$ Million)

Table 81. Arbor Pharmaceuticals Recent Developments

Table 82. Mayfield Brain & Spine Company Details

Table 83. Mayfield Brain & Spine Business Overview

Table 84. Mayfield Brain & Spine Aneurysmal Subarachnoid Hemorrhage Product

Table 85. Mayfield Brain & Spine Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023) & (US$ Million)

Table 86. Mayfield Brain & Spine Recent Developments

Table 87. Europa Group Company Details

Table 88. Europa Group Business Overview

Table 89. Europa Group Aneurysmal Subarachnoid Hemorrhage Product

Table 90. Europa Group Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023) & (US$ Million)

Table 91. Europa Group Recent Developments

Table 92. GE Company Details

Table 93. GE Business Overview

Table 94. GE Aneurysmal Subarachnoid Hemorrhage Product

Table 95. GE Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023) & (US$ Million)

Table 96. GE Recent Developments

Table 97. Philips Company Details

Table 98. Philips Business Overview

Table 99. Philips Aneurysmal Subarachnoid Hemorrhage Product

Table 100. Philips Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023) & (US$ Million)

Table 101. Philips Recent Developments

Table 102. Siemens Company Details

Table 103. Siemens Business Overview

Table 104. Siemens Aneurysmal Subarachnoid Hemorrhage Product

Table 105. Siemens Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023) & (US$ Million)

Table 106. Siemens Recent Developments

Table 107. Trivitron Company Details

Table 108. Trivitron Business Overview

Table 109. Trivitron Aneurysmal Subarachnoid Hemorrhage Product

Table 110. Trivitron Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023) & (US$ Million)

Table 111. Trivitron Recent Developments

Table 112. Toshiba Company Details

Table 113. Toshiba Business Overview

Table 114. Toshiba Aneurysmal Subarachnoid Hemorrhage Product

Table 115. Toshiba Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023) & (US$ Million)

Table 116. Toshiba Recent Developments

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Aneurysmal Subarachnoid Hemorrhage Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Type: 2022 VS 2029

Figure 3. Computed Tomography (CT) Scan Features

Figure 4. Magnetic Resonance Imaging (MRI) Features

Figure 5. Lumbar Puncture Features

Figure 6. Xanthochromia Features

Figure 7. Cerebral Angiography Features

Figure 8. Transcranial Doppler Ultrasound Features

Figure 9. Global Aneurysmal Subarachnoid Hemorrhage Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 10. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Application: 2022 VS 2029

Figure 11. Hospitals Case Studies

Figure 12. Clinics Case Studies

Figure 13. Others Case Studies

Figure 14. Aneurysmal Subarachnoid Hemorrhage Report Years Considered

Figure 15. Global Aneurysmal Subarachnoid Hemorrhage Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 16. Global Aneurysmal Subarachnoid Hemorrhage Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 17. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Region: 2022 VS 2029

Figure 18. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Players in 2022

Figure 19. Global Top Aneurysmal Subarachnoid Hemorrhage Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aneurysmal Subarachnoid Hemorrhage as of 2022)

Figure 20. The Top 10 and 5 Players Market Share by Aneurysmal Subarachnoid Hemorrhage Revenue in 2022

Figure 21. North America Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 22. North America Aneurysmal Subarachnoid Hemorrhage Market Share by Type (2018-2029)

Figure 23. North America Aneurysmal Subarachnoid Hemorrhage Market Share by Application (2018-2029)

Figure 24. North America Aneurysmal Subarachnoid Hemorrhage Market Share by Country (2018-2029)

Figure 25. United States Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 26. Canada Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 27. Europe Aneurysmal Subarachnoid Hemorrhage Market Size YoY (2018-2029) & (US$ Million)

Figure 28. Europe Aneurysmal Subarachnoid Hemorrhage Market Share by Type (2018-2029)

Figure 29. Europe Aneurysmal Subarachnoid Hemorrhage Market Share by Application (2018-2029)

Figure 30. Europe Aneurysmal Subarachnoid Hemorrhage Market Share by Country (2018-2029)

Figure 31. Germany Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. France Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. U.K. Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. Italy Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. Russia Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 36. Nordic Countries Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 37. China Aneurysmal Subarachnoid Hemorrhage Market Size YoY (2018-2029) & (US$ Million)

Figure 38. China Aneurysmal Subarachnoid Hemorrhage Market Share by Type (2018-2029)

Figure 39. China Aneurysmal Subarachnoid Hemorrhage Market Share by Application (2018-2029)

Figure 40. Asia Aneurysmal Subarachnoid Hemorrhage Market Size YoY (2018-2029) & (US$ Million)

Figure 41. Asia Aneurysmal Subarachnoid Hemorrhage Market Share by Type (2018-2029)

Figure 42. Asia Aneurysmal Subarachnoid Hemorrhage Market Share by Application (2018-2029)

Figure 43. Asia Aneurysmal Subarachnoid Hemorrhage Market Share by Region (2018-2029)

Figure 44. Japan Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. South Korea Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. China Taiwan Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. Southeast Asia Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 48. India Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 49. Australia Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Size YoY (2018-2029) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Share by Type (2018-2029)

Figure 52. Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Share by Application (2018-2029)

Figure 53. Middle East, Africa, and Latin America Aneurysmal Subarachnoid Hemorrhage Market Share by Country (2018-2029)

Figure 54. Brazil Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. Mexico Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. Turkey Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 57. Saudi Arabia Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 58. Israel Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 59. GCC Countries Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 60. Edge Therapeutics Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

Figure 61. Actelion Pharmaceuticals Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

Figure 62. Arbor Pharmaceuticals Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

Figure 63. Mayfield Brain & Spine Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

Figure 64. Europa Group Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

Figure 65. GE Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

Figure 66. Philips Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

Figure 67. Siemens Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

Figure 68. Trivitron Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

Figure 69. Toshiba Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2018-2023)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Aneurysmal Subarachnoid Hemorrhage Market Insights, Forecast to 2029

Published Date: May 2023

Report Code: QYRE-Auto-8O6254

Global Aneurysmal Subarachnoid Hemorrhage Market Insights, Forecast to 2029

FEATURED COMPANIES

Aneurysmal Subarachnoid Hemorrhage Market Size

Aneurysmal Subarachnoid Hemorrhage Market

Scope of Aneurysmal Subarachnoid Hemorrhage Market Report

Chapter Outline

FEATURED COMPANIES

RELATED REPORTS